Tailored Sonidegib Schedule After Complete Response in BCC
Status:
Recruiting
Trial end date:
2026-01-12
Target enrollment:
Participant gender:
Summary
Adult patients with locally advanced BCC, not amenable to surgical treatment and who obtained
a complete response (CR) to Hedgehog inhibitors are administered a tailored schedule of the
study drug. The tailored schedule consists of a change in the time of drug assumption. It
implements some weeks of assumption and some weeks of suspension of sonidegib rather than a
continuous administration.